Saturday 25 October 2014
 
»
Tag
 
»
Pharmaceuticals

$4bn Saudi pharma sector 'to maintain strong growth'

Saudi Arabia's pharmaceutical industry grew to $4 billion last year from $3 billion in 2008, said an industry expert, adding that the sector is expected to maintain its strong growth momentum. “However, a gradual shift t

More…

Roche names new ME sub-region head

Roche’s pharmaceuticals division has promoted Ehab Yousef to the newly created role of sub-region head for Middle East, overseeing the market activities in GCC region, Egypt and Yemen. Tthe move results from an effort by the

More…

Pfizer ends $118bn AstraZeneca takeover fight

Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the British drugmaker. The decision ends a month-long public f

More…

AstraZeneca rejects Pfizer's new $118bn offer

Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer, casting serious doubt on the US drugmaker's plan for a merger to create the world's biggest pharmaceuticals group. The rebuf

More…

Pfizer chasing AstraZeneca in $100bn-plus deal

US drugmaker Pfizer wants to buy AstraZeneca in a deal that could value its smaller British rival at more than $100 billion, creating a new giant on the global pharmaceuticals scene. Pfizer confirmed on Monday it made a bid approa

More…

Pfizer chasing AstraZeneca in $100bn-plus deal

US drugmaker Pfizer wants to buy AstraZeneca in a deal that could value its smaller British rival at more than $100 billion, creating a new giant on the global pharmaceuticals scene. Pfizer confirmed on Monday it made a bid approa

More…

Julphar in deal to produce, market MSD drugs

MSD, a global healthcare firm, and Julphar, a UAE-based pharmaceutical company, have signed a five-year agreement, which provides Julphar with exclusive rights to produce, market, distribute and sell certain MSD medicines in the region.

More…

Julphar in deal to produce, market MSD drugs

MSD, a global healthcare firm, and Julphar, a UAE-based pharmaceutical company, have signed a five-year agreement, which provides Julphar with exclusive rights to produce, market, distribute and sell certain MSD medicines in the region.

More…

Hikma’s H1 revenue hits $523m, up 35pc

UK-based Hikma Pharmaceuticals, a fast growing global pharmaceutical group, has posted revenue of $532.3 million for the first half of the year, marking a 34.8 per cent increase over the same period last year. The group, with sales in m

More…

Covidien may sell drugs unit for $4bn

Covidien is looking to sell its pharmaceuticals unit for as much as $4 billion, a source familiar with the situation said on Tuesday. JPMorgan Chase is advising Covidien on the matter, said the source, who declined to be named because the

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads